Very recently, in NAFLD patients, an activation of miR-34a/SIRT1/p53 pathway has been described to be correlated with the degree of the disease from steatosis to more severe NASH [55]. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatohepatitis.